- Published on
Ophthalmology – Craniosynostoses
Craniosynostoses are a group of craniofacial disorders characterized by premature fusion of one or more cranial sutures, leading to abnormal skull growth (craniostenosis). They are broadly classified into simple craniosynostosis (single suture involvement) and compound craniosynostosis (multiple sutures). These may occur as primary (genetic) conditions or secondary to other systemic disorders.
The condition is most commonly genetic, with several well-known syndromic associations. Crouzon syndrome is the most common craniosynostosis syndrome, followed by Apert syndrome, Pfeiffer syndrome, and Saethre–Chotzen syndrome. These are typically inherited in an autosomal dominant pattern and often involve mutations in fibroblast growth factor receptor genes (FGFR2, FGFR3, FGFR1) or transcription factors like TWIST1. Advanced paternal or maternal age is associated with new mutations in some syndromes.
Pathophysiologically, premature closure of a cranial suture restricts skull growth perpendicular to that suture while allowing compensatory growth parallel to it (Virchow’s law). This results in characteristic cranial deformities and may lead to increased intracranial pressure, abnormal brain development, and orbital abnormalities.
Ophthalmic involvement is common and clinically significant. Up to 90% of vision loss is due to amblyopia, while the remainder is related to structural abnormalities. Patients may exhibit proptosis (exorbitism) due to shallow orbits, leading to corneal exposure and risk of keratopathy. Other findings include strabismus (often exotropia), refractive errors, telecanthus, hypertelorism, nasolacrimal duct obstruction, and optic nerve abnormalities such as papilledema or compression. Eyelid abnormalities such as ptosis, coloboma, entropion, or ectropion may also be present.
Diagnosis involves a combination of clinical examination, family history, and genetic testing. Imaging plays a key role, particularly CT scans with 3D reconstruction to evaluate suture fusion and craniofacial anatomy, along with MRI when intracranial structures need assessment. Evaluation is multidisciplinary, involving ophthalmology, neurosurgery, genetics, and craniofacial teams.
Management is complex and requires a multidisciplinary approach. Early intervention focuses on relieving intracranial pressure and allowing normal brain growth, often via cranial vault surgery. Later procedures aim to correct orbital position and facial structure. Ophthalmologic care is essential for managing amblyopia, strabismus, exposure keratopathy, and optic nerve monitoring. Surgical interventions such as tarsorrhaphy, eyelid reconstruction, or strabismus surgery may be required.
Long-term follow-up is critical. Patients must be monitored for visual development, corneal exposure, optic nerve changes (papilledema), and ocular alignment issues. With timely and coordinated care, many complications—especially visual loss—can be minimized, although outcomes depend on the severity of the syndrome and associated abnormalities.
Craniosynostoses are a group of craniofacial disorders characterized by premature fusion of one or more cranial sutures, leading to abnormal skull growth (craniostenosis). They are broadly classified into simple craniosynostosis (single suture involvement) and compound craniosynostosis (multiple sutures). These may occur as primary (genetic) conditions or secondary to other systemic disorders.
The condition is most commonly genetic, with several well-known syndromic associations. Crouzon syndrome is the most common craniosynostosis syndrome, followed by Apert syndrome, Pfeiffer syndrome, and Saethre–Chotzen syndrome. These are typically inherited in an autosomal dominant pattern and often involve mutations in fibroblast growth factor receptor genes (FGFR2, FGFR3, FGFR1) or transcription factors like TWIST1. Advanced paternal or maternal age is associated with new mutations in some syndromes.
Pathophysiologically, premature closure of a cranial suture restricts skull growth perpendicular to that suture while allowing compensatory growth parallel to it (Virchow’s law). This results in characteristic cranial deformities and may lead to increased intracranial pressure, abnormal brain development, and orbital abnormalities.
Ophthalmic involvement is common and clinically significant. Up to 90% of vision loss is due to amblyopia, while the remainder is related to structural abnormalities. Patients may exhibit proptosis (exorbitism) due to shallow orbits, leading to corneal exposure and risk of keratopathy. Other findings include strabismus (often exotropia), refractive errors, telecanthus, hypertelorism, nasolacrimal duct obstruction, and optic nerve abnormalities such as papilledema or compression. Eyelid abnormalities such as ptosis, coloboma, entropion, or ectropion may also be present.
Diagnosis involves a combination of clinical examination, family history, and genetic testing. Imaging plays a key role, particularly CT scans with 3D reconstruction to evaluate suture fusion and craniofacial anatomy, along with MRI when intracranial structures need assessment. Evaluation is multidisciplinary, involving ophthalmology, neurosurgery, genetics, and craniofacial teams.
Management is complex and requires a multidisciplinary approach. Early intervention focuses on relieving intracranial pressure and allowing normal brain growth, often via cranial vault surgery. Later procedures aim to correct orbital position and facial structure. Ophthalmologic care is essential for managing amblyopia, strabismus, exposure keratopathy, and optic nerve monitoring. Surgical interventions such as tarsorrhaphy, eyelid reconstruction, or strabismus surgery may be required.
Long-term follow-up is critical. Patients must be monitored for visual development, corneal exposure, optic nerve changes (papilledema), and ocular alignment issues. With timely and coordinated care, many complications—especially visual loss—can be minimized, although outcomes depend on the severity of the syndrome and associated abnormalities.
0 Comments
